Whitney Ijem

Stock Analyst at Canaccord Genuity

(0)
# 4069
Out of 5,218 analysts
87
Total ratings
43.64%
Success rate
-4.08%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
Rhythm Pharmaceutica...
Maintains: Buy
80 80
55.28 44.72% 5 Nov 19, 2024
Rocket Pharmaceutica...
Maintains: Buy
39 39
12.02 224.46% 5 Nov 19, 2024
Intellia Therapeutic...
Maintains: Buy
90 90
12.89 598.22% 5 Nov 19, 2024
Taysha Gene Therapie...
Maintains: Strong Buy
6 8
2.06 288.35% 8 Nov 15, 2024
Passage Bio
Maintains: Buy
13 13
0.74 1656.76% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
121 121
45.88 163.73% 7 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
148 150
123.57 21.39% 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 32
5.72 459.44% 4 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
361 408
463.5 -11.97% 7 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
366 384
245.25 56.57% 6 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 84
66.03 27.21% 8 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 16
2.75 481.82% 5 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
11 28
1.58 1672.15% 4 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
87 86
17.2 400% 4 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 30
n/a n/a 2 Jul 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
1.15 682.61% 1 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Feb 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
8 16
0.7 2185.71% 4 Jul 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
33 0
n/a n/a 2 Feb 26, 2018